Table S2 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

MLA

Sabina Signoretti, et al. Table S2 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22458771.v1.

APA

Sabina Signoretti, Kathryn P. Gray, Daniel Y.C. Heng, David F. McDermott, Joaquim Bellmunt, Sumanta Kumar Pal, Camillo Porta, Katherine M. Krajewski, Eliezer M. Van Allen, M. Dror Michaelson, Pablo M. Barrios, Jean-Christophe Pignon, Jiaxi Song, Thai H. Ho, Neeraj Agarwal, Laurence Albiges, Lana Hamieh, Magdalena E. Tyburczy, Guillermo de Velasco, … David J. Kwiatkowski. (2023). Table S2 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. https://doi.org/10.1158/1078-0432.22458771.v1

Chicago

Sabina Signoretti, Kathryn P. Gray, Daniel Y.C. Heng, David F. McDermott, Joaquim Bellmunt, Sumanta Kumar Pal, Camillo Porta, et al. 2023. “Table S2 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma,” March. doi:10.1158/1078-0432.22458771.v1.